Pharm-Rx Fondaparinux Sodium USP
- CAS Number
- 114870-03-0
- Chemical Name
- Fondaparinux Sodium
- Molecular Formula
- C₃₁H₄₃N₃O₄₉S₈Na₁₀
Product families
Applications
- Other Drug & Care Solutions
Product Families
- Active Pharmaceutical Ingredients (APIs)
Other characteristics
- Certifications & Compliance
- United States Pharmacopeia (USP)
- Markets
- Healthcare & Pharma
- Defination
Fondaparinux Sodium is the sodium salt of a synthetic sulfated pentasaccharide anticoagulant based on the antithrombin binding moiety of heparin. It is synthesized from a natural source of chirally pure sugars (mono- and di-saccharides). A range of coupling, (de)protection and functionalization reactions leads to crude fondaparinux sodium, which is further purified to yield the drug substance. Fondaparinux Sodium contains NLT 95.0% and NMT 103.0% of fondaparinux sodium, calculated on the anhydrous and solvent-free basis. Fondaparinux Sodium is a white to off-white powder.
- Technology
- Pharmaceuticals & Nutraceuticals
- FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
- Storage Information
Preserve in tight containers, and store at or below 25° in a dry environment.
- USP Reference Standards
USP Fondaparinux Sodium for Assay RS; USP Fondaparinux Sodium Identification RS; USP Fondaparinux Sodium System Suitability Mixture ASolution RS
- Certifications and Compliance
- United States Pharmacopeia (USP)
Technical data
Table 1 of 1
1 row| Characteristic | Value |
|---|---|
| Molecular Weight | 1728.08 |
